Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.

The anti-aging gene, klotho, has been identified as a multi-functional humoral factor and is implicated in multiple biological processes. However, the effects of klotho on podocyte injury in diabetic nephropathy are poorly understood. Thus, the current study aims to investigate the renoprotective ef...

Full description

Bibliographic Details
Main Authors: Jeong Suk Kang, Seung Seob Son, Ji-Hye Lee, Seong Woo Lee, Ah Reum Jeong, Eun Soo Lee, Seung-Kuy Cha, Choon Hee Chung, Eun Young Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0250666
_version_ 1818364321427619840
author Jeong Suk Kang
Seung Seob Son
Ji-Hye Lee
Seong Woo Lee
Ah Reum Jeong
Eun Soo Lee
Seung-Kuy Cha
Choon Hee Chung
Eun Young Lee
author_facet Jeong Suk Kang
Seung Seob Son
Ji-Hye Lee
Seong Woo Lee
Ah Reum Jeong
Eun Soo Lee
Seung-Kuy Cha
Choon Hee Chung
Eun Young Lee
author_sort Jeong Suk Kang
collection DOAJ
description The anti-aging gene, klotho, has been identified as a multi-functional humoral factor and is implicated in multiple biological processes. However, the effects of klotho on podocyte injury in diabetic nephropathy are poorly understood. Thus, the current study aims to investigate the renoprotective effects of klotho against podocyte injury in diabetic nephropathy. We examined lipid accumulation and klotho expression in the kidneys of diabetic patients and animals. We stimulated cultured mouse podocytes with palmitate to induce lipotoxicity-mediated podocyte injury with or without recombinant klotho. Klotho level was decreased in podocytes of lipid-accumulated obese diabetic kidneys and palmitate-treated mouse podocytes. Palmitate-treated podocytes showed increased apoptosis, intracellular ROS, ER stress, inflammation, and fibrosis, and these were significantly attenuated by klotho administration. Klotho treatment restored palmitate-induced downregulation of the antioxidant molecules, Nrf2, Keap1, and SOD1. Klotho inhibited the phosphorylation of FOXO3a, promoted its nuclear translocation, and then upregulated MnSOD expression. In addition, klotho administration attenuated palmitate-induced cytoskeleton changes, decreased nephrin expression, and increased TRPC6 expression, eventually improving podocyte albumin permeability. These results suggest that klotho administration prevents palmitate-induced functional and morphological podocyte injuries, and this may indicate that klotho is a potential therapeutic agent for the treatment of podocyte injury in obese diabetic nephropathy.
first_indexed 2024-12-13T22:02:31Z
format Article
id doaj.art-eee64d9859f1441b8eaaed9ea07f676d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T22:02:31Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-eee64d9859f1441b8eaaed9ea07f676d2022-12-21T23:29:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01164e025066610.1371/journal.pone.0250666Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.Jeong Suk KangSeung Seob SonJi-Hye LeeSeong Woo LeeAh Reum JeongEun Soo LeeSeung-Kuy ChaChoon Hee ChungEun Young LeeThe anti-aging gene, klotho, has been identified as a multi-functional humoral factor and is implicated in multiple biological processes. However, the effects of klotho on podocyte injury in diabetic nephropathy are poorly understood. Thus, the current study aims to investigate the renoprotective effects of klotho against podocyte injury in diabetic nephropathy. We examined lipid accumulation and klotho expression in the kidneys of diabetic patients and animals. We stimulated cultured mouse podocytes with palmitate to induce lipotoxicity-mediated podocyte injury with or without recombinant klotho. Klotho level was decreased in podocytes of lipid-accumulated obese diabetic kidneys and palmitate-treated mouse podocytes. Palmitate-treated podocytes showed increased apoptosis, intracellular ROS, ER stress, inflammation, and fibrosis, and these were significantly attenuated by klotho administration. Klotho treatment restored palmitate-induced downregulation of the antioxidant molecules, Nrf2, Keap1, and SOD1. Klotho inhibited the phosphorylation of FOXO3a, promoted its nuclear translocation, and then upregulated MnSOD expression. In addition, klotho administration attenuated palmitate-induced cytoskeleton changes, decreased nephrin expression, and increased TRPC6 expression, eventually improving podocyte albumin permeability. These results suggest that klotho administration prevents palmitate-induced functional and morphological podocyte injuries, and this may indicate that klotho is a potential therapeutic agent for the treatment of podocyte injury in obese diabetic nephropathy.https://doi.org/10.1371/journal.pone.0250666
spellingShingle Jeong Suk Kang
Seung Seob Son
Ji-Hye Lee
Seong Woo Lee
Ah Reum Jeong
Eun Soo Lee
Seung-Kuy Cha
Choon Hee Chung
Eun Young Lee
Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
PLoS ONE
title Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
title_full Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
title_fullStr Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
title_full_unstemmed Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
title_short Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
title_sort protective effects of klotho on palmitate induced podocyte injury in diabetic nephropathy
url https://doi.org/10.1371/journal.pone.0250666
work_keys_str_mv AT jeongsukkang protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy
AT seungseobson protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy
AT jihyelee protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy
AT seongwoolee protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy
AT ahreumjeong protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy
AT eunsoolee protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy
AT seungkuycha protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy
AT choonheechung protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy
AT eunyounglee protectiveeffectsofklothoonpalmitateinducedpodocyteinjuryindiabeticnephropathy